Should We Use Prognostic Indices and/or Biomarkers to Guide Therapy in Follicular Lymphoma?

被引:0
作者
Okosun, Jessica [1 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England
关键词
Follicular lymphoma; prognostic; predictive; biomarker; PET; RISK; VALIDATION; RITUXIMAB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S11 / S13
页数:3
相关论文
共 25 条
  • [1] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
    Ardeshna, KM
    Smith, P
    Norton, A
    Hancock, BW
    Hoskin, PJ
    MacLennan, KA
    Marcus, RE
    Jelliffe, A
    Hudson, GV
    Linch, DC
    [J]. LANCET, 2003, 362 (9383) : 516 - 522
  • [2] A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
    Bachy, Emmanuel
    Maurer, Matthew J.
    Habermann, Thomas M.
    Gelas-Dore, Benedicte
    Maucort-Boulch, Delphine
    Estell, Jane A.
    Van den Neste, Eric
    Bouabdallah, Reda
    Gyan, Emmanuel
    Feldman, Andrew L.
    Bargay, Joan
    Delmer, Alain
    Slager, Susan L.
    da Silva, Maria Gomes
    Fitoussi, Olivier
    Belada, David
    Maisonneuve, Herve
    Intragumtornchai, Tanin
    Ansell, Stephen M.
    Lamy, Thierry
    Dartigues, Peggy
    Link, Brian K.
    Seymour, John F.
    Cerhan, James R.
    Salles, Gilles
    [J]. BLOOD, 2018, 132 (01) : 49 - 58
  • [3] Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma
    Bolen, Christopher R.
    Mattiello, Federico
    Herold, Michael
    Hiddemann, Wolfgang
    Huet, Sarah
    Klapper, Wolfram
    Marcus, Robert
    Mir, Farheen
    Salles, Gilles
    Weigert, Oliver
    Nielsen, Tina
    Oestergaard, Mikkel Z.
    Venstrom, Jeffrey M.
    [J]. BLOOD, 2021, 137 (19) : 2704 - 2707
  • [4] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
    Casulo, Carla
    Byrtek, Michelle
    Dawson, Keith L.
    Zhou, Xiaolei
    Farber, Charles M.
    Flowers, Christopher R.
    Hainsworth, John D.
    Maurer, Matthew J.
    Cerhan, James R.
    Link, Brian K.
    Zelenetz, Andrew D.
    Friedberg, Jonathan W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) : 2516 - U55
  • [5] Does MRD have a role in the management of iNHL?
    Del Giudice, Ilaria
    Della Starza, Irene
    Foa, Robin
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 320 - 330
  • [6] Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
    Federico, Massimo
    Caballero Barrigon, Maria Dolores
    Marcheselli, Luigi
    Tarantino, Vittoria
    Manni, Martina
    Sarkozy, Clementine
    Alonso-Alvarez, Sara
    Wondergem, Marielle
    Cartron, Guillaume
    Lopez-Guillermo, Armando
    Issa, Djamila
    Morschhauser, Franck
    Alcoceba, Miguel
    Kimby, Eva
    Rusconi, Chiara
    Chamuleau, Martine
    Holte, Harald
    Lockmer, Sandra
    Montoto, Silvia
    da Silva, Maria Gomes
    Aurer, Igor
    Zucca, Emanuele
    Paszkiewicz-Kozik, Ewa
    Minoia, Carla
    Skrypets, Tetiana
    Blaker, Yngvild Nuvin
    Salles, Gilles
    Coiffier, Bertrand
    [J]. LANCET HAEMATOLOGY, 2018, 5 (08): : E359 - E367
  • [7] Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
    Federico, Massimo
    Bellei, Monica
    Marcheselli, Luigi
    Luminari, Stefano
    Lopez-Guillermo, Armando
    Vitolo, Umberto
    Pro, Barbara
    Pileri, Stefano
    Pulsoni, Alessandro
    Soubeyran, Pierre
    Cortelazzo, Sergio
    Martinelli, Giovanni
    Martelli, Maurizio
    Rigacci, Luigi
    Arcaini, Luca
    Di Raimondo, Francesco
    Merli, Francesco
    Sabattini, Elena
    McLaughlin, Peter
    Solal-Celigny, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4555 - 4562
  • [8] A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
    Huet, Sarah
    Tesson, Bruno
    Jais, Jean-Philippe
    Feldman, Andrew L.
    Magnano, Laura
    Thomas, Emilie
    Traverse-Glehen, Alexandra
    Albaud, Benoit
    Carrere, Marjorie
    Xerri, Luc
    Ansell, Stephen M.
    Baseggio, Lucile
    Reyes, Cecile
    Tarte, Karin
    Boyault, Sandrine
    Haioun, Corinne
    Link, Brian K.
    Feugier, Pierre
    Lopez-Guillermo, Armando
    Tilly, Herve
    Brice, Pauline
    Hayette, Sandrine
    Jardin, Fabrice
    Offner, Fritz
    Sujobert, Pierre
    Gentien, David
    Viari, Alain
    Campo, Elias
    Cerhan, James R.
    Salles, Gilles
    [J]. LANCET ONCOLOGY, 2018, 19 (04) : 549 - 561
  • [9] Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy
    Jurinovic, Vindi
    Passerini, Verena
    Oestergaard, Mikkel Z.
    Knapp, Andrea
    Mundt, Kirsten
    Araf, Shamzah
    Richter, Julia
    Fitzgibbon, Jude
    Klapper, Wolfram
    Marcus, Robert E.
    Davies, Andrew
    Herold, Michael
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Hoster, Eva
    Weigert, Oliver
    [J]. BLOOD, 2019, 134
  • [10] Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
    Luminari, Stefano
    Manni, Martina
    Galimberti, Sara
    Versari, Annibale
    Tucci, Alessandra
    Boccomini, Carola
    Farina, Lucia
    Olivieri, Jacopo
    Marcheselli, Luigi
    Guerra, Luca
    Ferrero, Simone
    Arcaini, Luca
    Cavallo, Federica
    Kovalchuk, Sofya
    Skrypets, Tetiana
    del Giudice, Ilaria
    Chauvie, Stephane
    Patti, Caterina
    Stelitano, Caterina
    Ricci, Francesca
    Pinto, Antonello
    Casaluci, Gloria Margiotta
    Zilioli, Vittorio R.
    Merli, Anna
    Ladetto, Marco
    Bolis, Silvia
    Pavone, Vincenzo
    Chiarenza, Annalisa
    Arcari, Annalisa
    Anastasia, Antonella
    Dondi, Alessandra
    Mannina, Donato
    Federico, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (07)